Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

DUBLIN — April 9, 2018 — Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval to begin an investigational device exemption (IDE) pivotal trial to evaluate the Symplicity Spyral(TM) renal denervation system in patients with high blood pressure (hypertension).

Thumbnail

Expert Coding Advice: Dr. Z on Advanced Cardiovascular Procedures, Including Impella and Heart Assist Devices

Offered in cooperation with Abiomed

Dr. Zielske and Sara will address recent changes in CPT and ICD-10 coding for heart assist systems and Impella devices. Learn from their deep insight into coding for cardiac devices and the key changes hospitals need to be aware of to gain full reimbursement for complex procedures in the cardiac cath lab. Get the latest on just-implemented code changes as of April 1, 2018. To get paid properly, you must code exactly. We’ll tell you how.

Thumbnail

AI platform beats cardiologists, classifies echos with 98% accuracy

An artificial intelligence (AI) platform outperformed board-certified cardiologists in classifying echocardiogram views, according to a study published online March 21 in Digital Medicine.

Thumbnail

Troponin test shows potential in detecting CAD—but imaging still needed to confirm

A high-sensitivity troponin I (hsTnI) assay was independently predictive of coronary artery disease (CAD) in patients with stable chest pain in the outpatient setting, researchers reported in JACC: Cardiovascular Imaging. However, it’s not ready to be used as a standalone diagnostic tool for CAD.

Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation

DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc (NYSE: MDT) today announced one-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front Advance(TM) Cryoballoon to isolate the pulmonary veins in patients with symptomatic persistent atrial fibrillation (AF).

Thumbnail

Closure devices used in PFO treatment more beneficial than medication alone

A new trial suggested patients exhibiting patent foramen ovale (PFO), who received a medical device to close the opening in the heart after a stroke, had better outcomes compared to patients who received only stroke-preventing medications.

Thumbnail

How deep learning is helping cardiologists—not threatening their jobs

Applying a deep learning approach to echocardiography could save clinicians time while improving diagnostic accuracy, one Georgia-based cardiologist reported at the American College of Cardiology’s annual meeting in Orlando, this year.

Thumbnail

Left ventricular structure aids in risk prediction for stroke survivors

Echocardiographic assessment of left ventricular (LV) geometry could help predict outcomes in stroke survivors, according to research published online March 5 in JACC: Cardiovascular Imaging.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.